Completed
Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer
NCT00532909
- Conditions
- Anal, Colon, and Rectal Cancers, Colon/Rectal Cancer, Colonic Diseases, +12 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States